Armando Anido is President at AUXILIUM PHARMACEUTICALS INC (AUXL). They have made 7 open-market trades across 3 companies since 2006, most recently 2026-06-26.
CIK 0001219866
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $219K since 2017, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ZYNE | SELL | 2023-09-13 | 2023-09-14 | $1.33 | $24K | -3.8% | N/A | N/A |
| ZYNE | SELL | 2023-01-23 | 2023-01-25 | $0.60 | $21K | -1.6% | -16.1% | -40.7% |
| ZYNE | SELL | 2022-07-19 | 2022-07-20 | $1.10 | $13K | -7.2% | -2.4% | -45.3% |
| SCYX | BUY | 2020-12-21 | 2020-12-23 | $6.25 | $31K | +4.8% | +14.2% | +15.9% |
| ZYNE | BUY | 2018-08-06 | 2018-08-07 | $5.96 | $89K | -3.4% | +13.2% | -9.4% |
| ZYNE | BUY | 2017-05-12 | 2017-05-16 | $19.70 | $99K | -2.4% | -13.4% | -67.0% |
| AUXL | SELL · 10b5-1 | 2011-10-07 | 2011-10-11 | $14.23 | $75K | N/A | N/A | N/A |
| AUXL | SELL · 10b5-1 | 2011-07-08 | 2011-07-12 | $20.30 | $107K | N/A | N/A | N/A |
| AUXL | SELL · 10b5-1 | 2011-03-08 | 2011-03-09 | $23.02 | $243K | N/A | N/A | N/A |
| AUXL | SELL · 10b5-1 | 2011-01-10 | 2011-01-12 | $23.22 | $245K | N/A | N/A | N/A |
| AUXL | SELL · 10b5-1 | 2010-04-12 | 2010-04-14 | $33.07 | $992K | N/A | N/A | N/A |
| AUXL | SELL · 10b5-1 | 2009-06-26 | 2009-06-30 | $30.30 | $909K | N/A | N/A | N/A |
| AUXL | SELL · 10b5-1 | 2009-03-16 | 2009-03-17 | $29.73 | $892K | N/A | N/A | N/A |
| MEDI | SELL | 2006-02-03 | 2006-02-07 | $32.69 | $378K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.